Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shea

Showing results (161-170 of 248) with videos related to

Pageof 25
Sort By:
Blood|March 31, 2012
Meeting the challenge of hematologic malignancies in sub-Saharan AfricaSatish Gopal, William A Wood, Stephanie J Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Synthesis and PET studies of fluorine-18-BMY 14802: a potential antipsychotic drugY S Ding, J S Fowler, S L Dewey, et al.
Synapse (New York, N.Y.)|October 1, 1994
Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawalJ S Fowler, N D Volkow, J Logan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patientsJ P Eder, A Elias, T C Shea, et al.
American Journal of Hematology|November 1, 2002
Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemiaHendrik W van Deventer, Melissa D Hall, Robert Z Orlowski, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 18, 2020
Evaluation of mobilization efficacy with an extended interval following plerixafor administrationSarah E Stump, Morgan Trepte, J Ryan Shaw, et al.
The Analyst|November 3, 2015
Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from bloodJoshua M Jackson, James B Taylor, Małgorzata A Witek, et al.
Leukemia & Lymphoma|April 10, 2009
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survivalThomas C Shea, Anne W Beaven, Dominic T Moore, et al.
Life Sciences|March 4, 2000
Evidence that gingko biloba extract does not inhibit MAO A and B in living human brainJ S Fowler, G J Wang, N D Volkow, et al.
Nucleic Acids Research|February 11, 1992
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s)P V Danenberg, T Horikoshi, M Volkenandt, et al.
Pageof 25

Showing results (161-170 of 248) with videos related to

Sort By:
Pageof 25
Blood|March 31, 2012
Meeting the challenge of hematologic malignancies in sub-Saharan AfricaSatish Gopal, William A Wood, Stephanie J Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Synthesis and PET studies of fluorine-18-BMY 14802: a potential antipsychotic drugY S Ding, J S Fowler, S L Dewey, et al.
Synapse (New York, N.Y.)|October 1, 1994
Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawalJ S Fowler, N D Volkow, J Logan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patientsJ P Eder, A Elias, T C Shea, et al.
American Journal of Hematology|November 1, 2002
Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemiaHendrik W van Deventer, Melissa D Hall, Robert Z Orlowski, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 18, 2020
Evaluation of mobilization efficacy with an extended interval following plerixafor administrationSarah E Stump, Morgan Trepte, J Ryan Shaw, et al.
The Analyst|November 3, 2015
Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from bloodJoshua M Jackson, James B Taylor, Małgorzata A Witek, et al.
Leukemia & Lymphoma|April 10, 2009
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survivalThomas C Shea, Anne W Beaven, Dominic T Moore, et al.
Life Sciences|March 4, 2000
Evidence that gingko biloba extract does not inhibit MAO A and B in living human brainJ S Fowler, G J Wang, N D Volkow, et al.
Nucleic Acids Research|February 11, 1992
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s)P V Danenberg, T Horikoshi, M Volkenandt, et al.
Pageof 25